For people with chronic skin conditions, telehealth altered how they care for their skin and their bodies by removing ...
Psoriasis is a skin condition that causes the formation of thick, scaly patches on the body. It’s commonly found on the elbows, knees or scalp but can occur nearly anywhere on the skin. Cold weather ...
The clearance is the first for an oral peptide that blocks IL-23, the target of popular medicines like Skyrizi and Tremfya. J ...
By Sriparna Roy March 18 (Reuters) - The U.S. Food and Drug Administration has approved Johnson & Johnson's oral pill for psoriasis, the company said on Wednesday, paving the way for a more convenient ...
The company said the FDA approved Icotyde to treat moderate to severe plaque psoriasis in adults and pediatric patients 12 ...
The product was developed especially for skin prone to psoriasis and is intended to help reduce flaking, roughness and the ...
Each August, Psoriasis Awareness Month shines a light on a condition affecting millions worldwide. This special time helps people understand psoriasis better. It also builds vital support for ...
Johnson & Johnson said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots.
Psoriasis is an inflammatory condition that speeds up the life cycle of skin cells, causing red, scaly patches that can be itchy, painful, or cracked. Managing psoriasis can be tricky: There are oral, ...
Johnson & Johnson (JNJ) stock is in focus as US approves its once-daily pill Icotyde developed with Protagonist Therapeutics (PTGX) for plaque psoriasis. Read more here.
Psoriasis is a chronic skin disease in which cells build up quickly, resulting in patches on the skin surface that may be red or discolored, scaly, and itchy. It can be mild to severe, and is the ...
What Is the Auspitz Sign? Auspitz sign is a distinctive mark seen when a skin plaque has been removed. Plaques (also called scales) are common in plaque psoriasis, but people with Darier′s disease and ...